Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China flag China · Delayed Price · Currency is CNY
34.17
-1.18 (-3.34%)
Apr 29, 2026, 3:04 PM CST
155.96%
Market Cap 6.70B
Revenue (ttm) 1.42B
Net Income (ttm) 125.44M
Shares Out 196.11M
EPS (ttm) 0.62
PE Ratio 55.11
Forward PE n/a
Dividend 0.20 (0.57%)
Ex-Dividend Date Nov 24, 2025
Volume 15,796,605
Average Volume 26,671,266
Open 39.00
Previous Close 35.35
Day's Range 34.15 - 39.00
52-Week Range 13.25 - 68.80
Beta 0.80
RSI 48.32
Earnings Date Apr 29, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 1,275
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002940
Full Company Profile

Financial Performance

In 2025, SHE:002940's revenue was 1.42 billion, a decrease of -5.84% compared to the previous year's 1.51 billion. Earnings were 125.44 million, an increase of 56.15%.

Financial Statements

News

There is no news available yet.